Standard therapies for ovarian cancer are derived from plant extracts, or are synthetic chemicals that were developed by pharmaceutical companies. These medications were tested in clinical trials in women with ovarian cancer, and only agents that displayed safety and anti-cancer effects received approval from the United States Food and Drug Administration. Once treatments receive approval, societies of clinical oncologists review the safety and efficacy information, and develop recommended treatment guidelines.
Based in Erie, PA.
Paula S. Cousins Ovarian and Endometrial Cancer Foundation Inc. is a 501(c)(3) organization and gifts are tax deductible as allowed by law.
Copyright 2021 Paula S. Cousins Ovarian and Endometrial Cancer Foundation Inc.
Designed by Partnership Erie, an Outreach Program of Penn State Erie.
All content found on the Paula’s Promise Website, including: text, images, audio, or other formats were created for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this Website.